Iaso Therapeutics Announces First Close in $1.25M Equity Series Seed Preferred Financing
jeff@orbit.digital2023-01-25T11:03:18-05:00Iaso Therapeutics, a Michigan State University startup developing novel technologies for next-generation vaccines, recently closed the first tranche of the company’s $1.25M Series Seed Preferred round of financing.